In contrast, Innella et al. reported that wild-type RET patients and carriers of moderate-risk variants differ only by family history, but not by clinical characteristics such as mean age at the time of diagnosis of MTC. The gene discussed is RET; the disease is medullary thyroid gland carcinoma.